Novartis' Vaccine Boost
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)
Published: 1 Aug-2007
DOI: 10.3833/pdr.v2007.i86.302 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The vaccine market is becoming more important to big pharma's business, which has resulted in larger deals being made in this area, as exemplified by the recent partnership between Intercell and Novartis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS